Patent details
EP4351582 Title: COMBINATION OF A PARTICULAR BRAF INHIBITOR (PARADOX BREAKER) AND A PD-1 AXIS BINDING ANTAGONIST FOR USE IN THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP4351582
- PCT Application Number:
- EP2022065373
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP227333416
- PCT Publication Number:
- WO2022258600
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF A PARTICULAR BRAF INHIBITOR (PARADOX BREAKER) AND A PD-1 AXIS BINDING ANTAGONIST FOR USE IN THE TREATMENT OF CANCER
- French Title of Invention:
- COMBINAISON D'UN INHIBITEUR PARTICULIER DE BRAF (BRISEUR DE PARADOXE) AVEC UN ANTAGONISTE SE LIANT À L'AXE PD-1 POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- KOMBINATION EINES BESTIMMTEN BRAF-INHIBITORS (PARADOXBRECHER) MIT EINEM PD-1 ACHSENBINDENDEN ANTAGONISTEN ZUR VERWENDUNG IN DER KREBSBEHANDLUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/10/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 14/10/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 08/10/2025
- Unitary Effect Registration Date:
- 14/10/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 07/06/2022
- Grant date:
- 08/10/2025
- EP Publication Date:
- 17/04/2024
- PCT Publication Date:
- 15/12/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/10/2025
- EP B1 Publication Date:
- 08/10/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 07/06/2042
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/10/2025
- Name:
- F. Hoffmann-La Roche AG
- Address:
- Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)
Inventor
1
- Name:
- HERTING, Frank
- Address:
- Germany (DE)
2
- Name:
- WICHMANN, Juergen
- Address:
- Switzerland (CH)
3
- Name:
- FRIESS, Thomas
- Address:
- Germany (DE)
4
- Name:
- PETTAZZONI, Piergiorgio Francesco Tommaso
- Address:
- Switzerland (CH)
5
- Name:
- ECKMANN, Jan
- Address:
- Germany (DE)
Priority
1
- Priority Number:
- 21178462
- Priority Date:
- 09/06/2021
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 22157499
- Priority Date:
- 18/02/2022
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/517; A61P 35/00; A61K 45/06; A61K 39/395; C07K 16/28;
Publication
European Patent Bulletin
1
- Issue number:
- 202541
- Publication date:
- 08/10/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202546
- Publication date:
- 12/11/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202546
- Publication date:
- 12/11/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|